Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is planned to evaluate the efficacy and safety of SIM0278 in adults with moderate to severe Atopic Dermatitis, with status NOT_YET_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SIM0278

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: NOT_YET_RECRUITING